Phenotype
|
Fish
|
Conditions
|
Figures
|
whole organism hspa5 expression increased amount, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
Fig. 3
from Serafini et al., 2018
|
eye physical object quality, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
text only
from Serafini et al., 2018
|
whole organism b4gat1 expression decreased amount, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
Fig. S2
from Serafini et al., 2018
|
muscle physical object quality, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
text only
from Serafini et al., 2018
|
thigmotaxis decreased occurrence, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
Fig. 2
from Serafini et al., 2018
|
locomotory behavior decreased occurrence, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
Fig. 2
from Serafini et al., 2018
|
whole organism xbp1 expression increased amount, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
Fig. 3
from Serafini et al., 2018
|
whole organism dag1 expression decreased amount, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
Fig. S2
from Serafini et al., 2018
|
brain physical object quality, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
text only
from Serafini et al., 2018
|
whole organism pomgnt2 expression decreased amount, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
Fig. S2
from Serafini et al., 2018
|
whole organism pomt1 expression decreased amount, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
Fig. S2
from Serafini et al., 2018
|
pericardium edematous, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
Fig. 1
from Serafini et al., 2018
|
whole organism decreased life span, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
text only
from Serafini et al., 2018
|
whole organism fkrp expression decreased amount, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
Fig. S2
from Serafini et al., 2018
|
whole organism large1 expression decreased amount, abnormal
|
fkrpuab203/uab203 (AB)
|
standard conditions
|
Fig. S2
from Serafini et al., 2018
|
pericardium edematous, abnormal
|
fkrpuab204/uab204 (AB)
|
standard conditions
|
Fig. 1
from Serafini et al., 2018
|
pericardium edematous, abnormal
|
fkrpuab205/uab205 (AB)
|
standard conditions
|
Fig. 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ornidazole
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ursolic acid
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ursolic acid
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, abnormal
|
fkrpuab203/uab203; uab202Tg
|
heat shock
|
Fig. 5
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: metampicillin sodium
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: alverine citrate
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: citric acid
|
Fig. 6
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: calycanthine
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: betulin
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: calycanthine
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ursolic acid
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: metaraminol bitartrate
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: oxymetazoline hydrochloride
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: sulfacetamide sodium
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: chlorphenesin carbamate
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: pentetic acid
|
Fig. 5,
Fig. 6
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: flumequine
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: sulfacetamide sodium
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ornidazole
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: sulfacetamide sodium
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: metaraminol bitartrate
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: metaraminol bitartrate
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: pentetic acid
|
Fig. 5,
Fig. 6
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: aztreonam
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: betulin
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: flumequine
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: metampicillin sodium
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: oxymetazoline hydrochloride
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: chlorphenesin carbamate
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: calycanthine
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: perphenazine
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: Thioproperazine mesilate
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: oxymetazoline hydrochloride
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: paclitaxel
|
Table 1
from Serafini et al., 2018
|
skeletal muscle cell organization quality, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock
|
Fig. 4
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: paclitaxel
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: perphenazine
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: flumequine
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: streptomycins
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ipratropium bromide
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: perphenazine
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: streptomycins
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: streptomycins
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: alverine citrate
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ornidazole
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: rimexolone
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: aztreonam
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: flumequine
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: paclitaxel
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ipratropium bromide
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: calycanthine
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: paclitaxel
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: metaraminol bitartrate
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ornidazole
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: Kawain
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: streptomycins
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: pirenzepine hydrochloride
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: aztreonam
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: betulin
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: calycanthine
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: pentetic acid
|
Fig. 5
from Serafini et al., 2018
|
pericardium edematous, abnormal
|
fkrpuab203/uab203; uab202Tg
|
heat shock
|
Fig. 5
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ornidazole
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ipratropium bromide
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: metampicillin sodium
|
Table 1
from Serafini et al., 2018
|
skeletal muscle cell disorganized, abnormal
|
fkrpuab203/uab203; uab202Tg
|
standard conditions
|
Fig. 4
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: triethanolamine
|
Fig. 6
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: Thioproperazine mesilate
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: betulin
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: triethanolamine
|
Fig. 6
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ursolic acid
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: perphenazine
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: aztreonam
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: rimexolone
|
Table 1
from Serafini et al., 2018
|
post-vent region bent, abnormal
|
fkrpuab203/uab203; uab202Tg
|
heat shock
|
Fig. 4
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: sulfacetamide sodium
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: metaraminol bitartrate
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ipratropium bromide
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: aztreonam
|
Table 1
from Serafini et al., 2018
|
whole organism decreased life span, abnormal
|
fkrpuab203/uab203; uab202Tg
|
heat shock
|
Fig. 5
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: chlorphenesin carbamate
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: Kawain
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: oxymetazoline hydrochloride
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: Kawain
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: alverine citrate
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: pirenzepine hydrochloride
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ipratropium bromide
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: chlorphenesin carbamate
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: sulfacetamide sodium
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: Thioproperazine mesilate
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: flumequine
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: Thioproperazine mesilate
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: oxymetazoline hydrochloride
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: pirenzepine hydrochloride
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: perphenazine
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: metampicillin sodium
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: alverine citrate
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: streptomycins
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: chlorphenesin carbamate
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: ursolic acid
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: betulin
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: citric acid
|
Fig. 6
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: rimexolone
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: paclitaxel
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: Kawain
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: alverine citrate
|
Table 1
from Serafini et al., 2018
|
whole organism life span, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: rimexolone
|
Table 1
from Serafini et al., 2018
|
skeletal muscle refractivity, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: Kawain
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: rimexolone
|
Table 1
from Serafini et al., 2018
|
pericardium structure, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: pirenzepine hydrochloride
|
Table 1
from Serafini et al., 2018
|
eye morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: Thioproperazine mesilate
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: metampicillin sodium
|
Table 1
from Serafini et al., 2018
|
head morphology, ameliorated
|
fkrpuab203/uab203; uab202Tg
|
heat shock, chemical treatment: pirenzepine hydrochloride
|
Table 1
from Serafini et al., 2018
|